Literature DB >> 16371373

Influenza related hospitalisations in Sydney, New South Wales, Australia.

F Beard1, P McIntyre, H Gidding, M Watson.   

Abstract

BACKGROUND: Routine influenza vaccination for children aged 6-23 months has recently been recommended in the United States. Accurate assessment of influenza related burden of illness in children could support similar recommendations in other settings. However, routinely available data underestimate the role of influenza in causing hospitalisation, and indirect estimation methods face difficulties controlling for the concurrent circulation of respiratory syncytial virus (RSV). Recent studies from Hong Kong and the United States have used differing methods to estimate the true burden of influenza related hospitalisation, with disparate results.
METHODS: Retrospective population based study of children less than 18 years of age from Sydney, Australia, 1994 to 2001. Using two previously reported methods, estimates of annual hospitalisation rates attributable to influenza were derived by comparison of mean hospitalisation rates for acute respiratory disease during periods of high influenza activity and low RSV activity (defined using virological surveillance data) and periods where both influenza and RSV activity were low. These estimates were compared to rates of hospitalisation where influenza was recorded as the principal discharge diagnosis.
RESULTS: Hospitalisation rates attributable to influenza were up to 11 times higher, depending on the age group and method used, compared to rates calculated from principal discharge diagnosis codes.
CONCLUSIONS: Although there remains considerable uncertainty in estimating influenza related morbidity by methods using excess hospitalisations, even minimum estimates of disease burden warrant consideration of routine influenza immunisation for all children less than 2 years of age. Such estimates, derived from principal discharge diagnosis codes, are available in most settings.

Entities:  

Mesh:

Year:  2006        PMID: 16371373      PMCID: PMC2083076          DOI: 10.1136/adc.2004.060707

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Is it time to give influenza vaccine to healthy infants?

Authors:  K McIntosh; T Lieu
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

2.  Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.

Authors:  R B Belshe; W C Gruber
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

3.  Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

Authors:  Kathleen M Neuzil; Yuwei Zhu; Marie R Griffin; Kathryn M Edwards; Juliette M Thompson; Sharon J Tollefson; Peter F Wright
Journal:  J Infect Dis       Date:  2001-12-17       Impact factor: 5.226

Review 4.  Cold-adapted influenza vaccines.

Authors:  John Bradshaw; Peter F Wright
Journal:  Curr Opin Pediatr       Date:  2002-02       Impact factor: 2.856

Review 5.  Reduction of the influenza burden in children.

Authors: 
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

6.  The Laboratory Virology and Serology Reporting Scheme, 1991 to 2000.

Authors:  Paul Roche; Linda Halliday; Eddie O'Brien; Jenean Spencer
Journal:  Commun Dis Intell Q Rep       Date:  2002

7.  Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000.

Authors:  Peter McIntyre; Heather Gidding; Robin Gilmour; Glenda Lawrence; Brynley Hull; Peter Horby; Han Wang; Ross Andrews; Margaret Burgess
Journal:  Commun Dis Intell Q Rep       Date:  2002-05

8.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

9.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

10.  Influenza-related hospitalizations among children in Hong Kong.

Authors:  Susan S Chiu; Yu Lung Lau; Kwok H Chan; Wilfred Hing Sang Wong; J S Malik Peiris
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

View more
  6 in total

Review 1.  Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain.

Authors:  J S Nguyen-Van-Tam
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

2.  Impact of weather factors on influenza hospitalization across different age groups in subtropical Hong Kong.

Authors:  Yapeng Li; Xi-Ling Wang; Xueying Zheng
Journal:  Int J Biometeorol       Date:  2018-05-26       Impact factor: 3.787

3.  Influenza hospitalizations in Australian children.

Authors:  J Li-Kim-Moy; J K Yin; C C Blyth; A Kesson; R Booy; A C Cheng; K Macartney
Journal:  Epidemiol Infect       Date:  2017-02-06       Impact factor: 4.434

4.  Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis.

Authors:  Benjamin G Polkinghorne; David J Muscatello; C Raina Macintyre; Glenda L Lawrence; Paul M Middleton; Siranda Torvaldsen
Journal:  BMC Infect Dis       Date:  2011-10-26       Impact factor: 3.090

Review 5.  Influenza immunization policies: Which could be the main reasons for differences among countries?

Authors:  Nicola Principi; Barbara Camilloni; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

Review 6.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.